GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $229,000 | -76.9% | 282,233 | -41.5% | 0.05% | -63.6% |
| Q3 2018 | $993,000 | -86.1% | 482,134 | -31.0% | 0.14% | -84.9% |
| Q2 2018 | $7,121,000 | +40.4% | 698,802 | -10.3% | 0.94% | +48.7% |
| Q1 2018 | $5,072,000 | +20.3% | 779,109 | +46.9% | 0.64% | +34.5% |
| Q4 2017 | $4,215,000 | -14.7% | 530,547 | +2.0% | 0.47% | -10.6% |
| Q3 2017 | $4,943,000 | +42.4% | 520,292 | +91.8% | 0.53% | +45.5% |
| Q2 2017 | $3,472,000 | – | 271,215 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exchange Capital Management, Inc. | 758,623 | $7,966,000 | 2.88% |
| Cormorant Asset Management, LP | 952,798 | $10,004,000 | 1.45% |
| DAFNA Capital Management LLC | 52,797 | $554,000 | 0.47% |
| HIGHLAND CAPITAL MANAGEMENT LP | 316,789 | $3,326,000 | 0.17% |
| Cambridge Investment Research Advisors, Inc. | 150,564 | $1,581,000 | 0.03% |
| NORRIS PERNE & FRENCH LLP/MI | 10,463 | $110,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 634,246 | $6,660,000 | 0.02% |
| SEGALL BRYANT & HAMILL, LLC | 11,000 | $116,000 | 0.00% |
| Acrospire Investment Management LLC | 400 | $4,000 | 0.00% |
| Advisor Group, Inc. | 5,112 | $54,000 | 0.00% |